Plasma-derived therapies play a crucial role in treating numerous chronic diseases, including rare neuromuscular conditions such as dysimmune inflammatory neuropathies. However, plasma is a limited resource, often facing shortages. To address this, EPODIN (the European Patients Organisation for Dysimmune and Inflammatory Neuropathies) has introduced a section on its website aimed at encouraging plasma donations and raising awareness about plasma therapies: https://www.epodin.org/plasma-donation/